Resumen de acción GALE
Galenica AG opera como proveedor de servicios sanitarios en Suiza y a escala internacional. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 4/6 |
| Crecimiento futuro | 2/6 |
| Rendimiento pasado | 4/6 |
| Salud financiera | 6/6 |
| Dividendos | 3/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en GALE a partir de nuestros controles de riesgos.
Competidores de Galenica AG
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | CHF 76.30 |
| Máximo en las últimas 52 semanas | CHF 78.15 |
| Mínimo de 52 semanas | CHF 69.30 |
| Beta | 0.18 |
| 1Cambio en 1 mes | 0.13% |
| Variación en 3 meses | 5.61% |
| Cambio de 1 año | 8.15% |
| 3Variación en 3 años | 16.05% |
| Variación en 5 años | 26.96% |
| Variación desde la OPV | 77.44% |
Noticias y actualizaciones recientes
Galenica AG's (VTX:GALE) Popularity With Investors Is Under Threat From Overpricing
Nov 12
Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Oct 05Galenica (VTX:GALE) Might Have The Makings Of A Multi-Bagger
Sep 17Earnings Not Telling The Story For Galenica AG (VTX:GALE)
Jul 31Is Galenica (VTX:GALE) Using Too Much Debt?
Jun 16Recent updates
Galenica AG's (VTX:GALE) Popularity With Investors Is Under Threat From Overpricing
Nov 12Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Oct 05Galenica (VTX:GALE) Might Have The Makings Of A Multi-Bagger
Sep 17Earnings Not Telling The Story For Galenica AG (VTX:GALE)
Jul 31Is Galenica (VTX:GALE) Using Too Much Debt?
Jun 16Galenica AG (VTX:GALE) Investors Are Less Pessimistic Than Expected
Apr 25We Think The Compensation For Galenica AG's (VTX:GALE) CEO Looks About Right
Apr 04Slowing Rates Of Return At Galenica (VTX:GALE) Leave Little Room For Excitement
Mar 29Pinning Down Galenica AG's (VTX:GALE) P/E Is Difficult Right Now
Jan 22Is There An Opportunity With Galenica AG's (VTX:GALE) 42% Undervaluation?
Jan 04Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes
Oct 26Is Galenica (VTX:GALE) Using Too Much Debt?
Oct 11Are Investors Undervaluing Galenica AG (VTX:GALE) By 42%?
Sep 26These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well
Jun 20Here's What To Make Of Galenica's (VTX:GALE) Decelerating Rates Of Return
Apr 17We Think Galenica (VTX:GALE) Can Stay On Top Of Its Debt
Mar 12Returns On Capital At Galenica (VTX:GALE) Have Hit The Brakes
Jan 08These 4 Measures Indicate That Galenica (VTX:GALE) Is Using Debt Reasonably Well
Nov 28The Returns At Galenica (VTX:GALE) Aren't Growing
Sep 20Is Galenica (VTX:GALE) A Risky Investment?
Aug 30Return Trends At Galenica (VTX:GALE) Aren't Appealing
Jun 15Galenica (VTX:GALE) Could Easily Take On More Debt
Apr 06Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward
Feb 15Should You Be Adding Galenica (VTX:GALE) To Your Watchlist Today?
Jan 02Does Galenica (VTX:GALE) Have A Healthy Balance Sheet?
Nov 30Returns At Galenica (VTX:GALE) Appear To Be Weighed Down
Oct 24With EPS Growth And More, Galenica (VTX:GALE) Is Interesting
Sep 25Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Aug 24Galenica (VTX:GALE) Has More To Do To Multiply In Value Going Forward
Jul 24If You Like EPS Growth Then Check Out Galenica (VTX:GALE) Before It's Too Late
Jun 12Investors Met With Slowing Returns on Capital At Galenica (VTX:GALE)
Apr 07Galenica (VTX:GALE) Seems To Use Debt Quite Sensibly
Mar 25Galenica AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Mar 11Is Galenica AG (VTX:GALE) The Right Choice For A Smart Dividend Investor?
Feb 27Are Institutions Heavily Invested In Galenica AG's (VTX:GALE) Shares?
Jan 31
Galenica (VTX:GALE) Shareholders Have Enjoyed A 25% Share Price Gain
Jan 13Is Galenica (VTX:GALE) Likely To Turn Things Around?
Dec 25Is Galenica (VTX:GALE) A Risky Investment?
Dec 09Is Galenica AG (VTX:GALE) An Attractive Dividend Stock?
Nov 24Rentabilidad de los accionistas
| GALE | CH Healthcare | Mercado CH | |
|---|---|---|---|
| 7D | -0.5% | -1.2% | -2.2% |
| 1Y | 8.2% | 7.3% | 6.2% |
Rentabilidad vs. Industria: GALE igualó a la industria Swiss Healthcare, que obtuvo un rendimiento del 7.3% el año pasado.
Rentabilidad vs. Mercado: GALE superó al mercado Swiss, que obtuvo un rendimiento del 6.2% el año pasado.
Volatilidad de los precios
| GALE volatility | |
|---|---|
| GALE Average Weekly Movement | 1.9% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 3.3% |
| 10% most volatile stocks in CH Market | 6.6% |
| 10% least volatile stocks in CH Market | 1.6% |
Precio estable de las acciones: GALE no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de GALE (2%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1927 | 7,955 | Marc Werner | www.galenica.com |
Galenica AG opera como proveedor de servicios sanitarios en Suiza y a escala internacional. Opera a través de dos segmentos, Products & Care, y Logistics & IT. El segmento Products & Care gestiona farmacias y farmacias asociadas con las marcas Amavita, Sun Store y Coop Vitality.
Resumen de fundamentos de Galenica AG
| Estadísticas fundamentales de GALE | |
|---|---|
| Capitalización bursátil | CHF 3.80b |
| Beneficios(TTM) | CHF 169.68m |
| Ingresos (TTM) | CHF 3.80b |
22.4x
Ratio precio-beneficio (PE)1.0x
Ratio precio-ventas (PS)¿Está GALE sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de GALE | |
|---|---|
| Ingresos | CHF 3.80b |
| Coste de los ingresos | CHF 3.34b |
| Beneficio bruto | CHF 464.58m |
| Otros gastos | CHF 294.90m |
| Beneficios | CHF 169.68m |
Últimos beneficios comunicados
Jun 30, 2024
Próxima fecha de beneficios
Mar 11, 2025
| Beneficios por acción (BPA) | 3.41 |
| Margen bruto | 12.22% |
| Margen de beneficio neto | 4.46% |
| Ratio deuda/patrimonio | 42.9% |
¿Cómo se ha desempeñado GALE a largo plazo?
Ver rendimiento histórico y comparativa